Last reviewed: May 30, 2026 Last updated: May 30, 2026 Written by: Jay Hastings , CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Nature 222 , 10671068 (1969)
It enhances absorption and stability of the semaglutide molecule
Peripherally, pancytopenia is most often observed, but only 1-2 of the major cell types (erythrocytes, leukocytes, platelets) may be depressed in some cases
Disclaimer: Healthletic BPC-157 is not intended to diagnose, treat, cure, or prevent any disease
The British Society of Haematology website still shows their guidelines as last reviewed in 2014 (yes not a typo, 10 years ago!)